Literature DB >> 2462536

T-cell modulation of the antibody response to bacterial polysaccharide antigens.

C E Taylor1, R Bright.   

Abstract

Pretreatment of mice with subimmunogenic doses of meningococcal polysaccharide (MP), Pseudomonas aeruginosa lipopolysaccharide (PA), or Streptococcus mutans polysaccharide (SM) resulted in suppression of antibody response. The transfer of putative suppressor T cells (Ts cells) from donor mice primed with a subimmunogenic dose of MP to naive recipients at the time of immunization with MP substantially reduced the magnitude of the antibody response. Also, the infusion of B cells taken from animals immunized with either MP or PA suppressed the antibody response of naive recipients to MP or PA, respectively, relative to controls, suggesting that Ts cells respond to determinants on immune B cells. We observed that the injection of concanavalin A or phytohemagglutinin (two lectins known to augment the activity of amplifier T cells [Ta cells]) 2 days postimmunization enhanced the antibody response to MP and SM. In addition, Ta-cell activity was transferred to naive animals by using spleen cells. Although the administration of phytohemagglutinin at the time of immunization with MP also resulted in increased antibody response, the injection of concanavalin A simultaneous with immunization resulted in a suppression of the antibody response to MP. Although Ts cells generated in response to pneumococcal polysaccharide type III were found to respond to monoclonal antibody Ly-m22, Ta cells responded to monoclonal antibodies L3T4 and Ia but not to Ly-m22. These studies suggest that Ta and Ts cells can modulate the antibody response to MP, SM, and PA in a positive and negative manner, respectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462536      PMCID: PMC313065          DOI: 10.1128/iai.57.1.180-185.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott; R F Barth
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

2.  The morphology of immune reactions in normal, thymectomized and reconstituted mice. 3. Response to bacterial antigens: salmonellar flagellar antigen and pneumococcal plysaccharide.

Authors:  A J Davies; R L Carter; E Leuchars; V Wallis; F M Dietrich
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

3.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

4.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

5.  Characteristics of amplifier T cells involved in the antibody response to the capsular polysaccharide of type III Streptococcus pneumoniae.

Authors:  C E Taylor; P W Stashak; J Chiang; W M Leiserson; G Caldes; B Prescott; P J Baker
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

6.  Detection and enumeration of antibody-producing cells by specific adherence of antigen-coated bentonite particles.

Authors:  P J Baker; M Bernstein; V Pasanen; M Landy
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

7.  Lectin-induced modulation of the antibody response to type III pneumococcal polysaccharide.

Authors:  C E Taylor; P W Stashak; G Caldes; B Prescott; B J Fowlkes; P J Baker
Journal:  Cell Immunol       Date:  1984-01       Impact factor: 4.868

8.  Prevention of Streptococcus mutans colonization by salivary IgA antibodies.

Authors:  R L Gregory; S M Michalek; S J Filler; J Mestecky; J R McGhee
Journal:  J Clin Immunol       Date:  1985-01       Impact factor: 8.317

9.  Altered antibody isotype in cystic fibrosis: possible role in opsonic deficiency.

Authors:  R B Moss; Y P Hsu; M M Sullivan; N J Lewiston
Journal:  Pediatr Res       Date:  1986-05       Impact factor: 3.756

10.  Regulation of IgG memory responses by helper and suppressor T cells activated by the type 2 antigen, polyvinylpyrrolidone.

Authors:  H Braley-Mullen
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.

Authors:  P J Baker
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Emergence of novel Streptococcus iniae exopolysaccharide-producing strains following vaccination with nonproducing strains.

Authors:  Marina Eyngor; Yoram Tekoah; Roni Shapira; Avshalom Hurvitz; Amir Zlotkin; Avishay Lublin; Avi Eldar
Journal:  Appl Environ Microbiol       Date:  2008-09-19       Impact factor: 4.792

3.  Immunogenicity of meningococcal polysaccharide ACWY vaccine in primary immunized or revaccinated adults.

Authors:  C Ferlito; R Biselli; M S Cattaruzza; R Teloni; S Mariotti; E Tomao; G Salerno; M S Peragallo; P Lulli; S Caporuscio; A Autore; G Bizzarro; V Germano; M I Biondo; A Picchianti Diamanti; S Salemi; R Nisini; R D'Amelio
Journal:  Clin Exp Immunol       Date:  2018-09-20       Impact factor: 4.330

4.  Dynamics of the murine humoral immune response to Neisseria meningitis group B capsular polysaccharide.

Authors:  J Colino; I Outschoorn
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  Atopic eczema is associated with delayed maturation of the antibody response to pneumococcal vaccine.

Authors:  P D Arkwright; L Patel; A Moran; M R Haeney; C I Ewing; T J David
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

6.  Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.

Authors:  P J Baker; T Hraba; C E Taylor; P W Stashak; M B Fauntleroy; U Zähringer; K Takayama; T R Sievert; X Hronowski; R J Cotter
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.

Authors:  G B Pier; S Takeda; M Grout; R B Markham
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

8.  Immunogenicity of Vibrio vulnificus capsular polysaccharides and polysaccharide-protein conjugates.

Authors:  J G Simonson; R J Siebeling
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Clonotypic analysis of human antibodies specific for Neisseria meningitidis polysaccharides A and C in adults.

Authors:  S Le Moli; P M Matricardi; I Quinti; T Stroffolini; R D'Amelio
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

10.  Enrichment of suppressor T cells by means of binding to monophosphoryl lipid A.

Authors:  P J Baker; K R Haslov; M B Fauntleroy; P W Stashak; K Myers; J T Ulrich
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.